Molecular epidemiology of major depressive disorder
Open Access
- 20 January 2009
- journal article
- review article
- Published by Springer Nature in Environmental Health and Preventive Medicine
- Vol. 14 (2) , 71-87
Abstract
Major depressive disorder causes significant morbidity, affecting people’s ability to work, function in relationships, and engage in social activities. Moreover, major depressive disorder increases the risk of suicidal ideation, attempted suicide and death by completed suicide. There is evidence that chronic stress can cause major depressive disorder. As for genetic factors, only minor susceptibility genes have been reliably identified. The serotonin system provides a logical source of susceptibility genes for depression, because this system is the target of selective serotonin reuptake-inhibitor drugs that are effective in treating depression. The 5-hydroxytryptamine (serotonin) transporter (5-HTT) has received particular attention because it is involved in the reuptake of serotonin at brain synapses. One common polymorphic variant of the 5-HTT-linked polymorphic region (5-HTTLPR), which affects the promoter of the 5-HTT gene, causes reduced uptake of the neurotransmitter serotonin into the presynaptic cells in the brain. The authors discussed the relationship between genetic polymorphisms and major depressive disorder, with special emphasis on the 5-HTTTLPR polymorphism. As the 5-HTTLPR polymorphism was significantly associated with an increased risk of major depressive disorder, the 5-HTT gene may be a candidate for a major depressive disorder susceptibility gene. As major depressive disorder is a multifactorial disease, an improved understanding of the interplay of environmental and genetic polymorphisms at multiple loci may help identify individuals who are at increased risk for major depressive disorder. Hopefully, in the future we will be able to screen for major depressive disorder susceptibility by using specific biomarkers.Keywords
This publication has 182 references indexed in Scilit:
- Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmissionPharmacology & Therapeutics, 2007
- Gender differences in adolescent depression: Do symptoms differ for boys and girls?Journal of Affective Disorders, 2005
- Association between COMT (Val158Met) functional polymorphism and early onset in patients with major depressive disorder in a European multicenter genetic association studyMolecular Psychiatry, 2004
- Serotonin transporter gene (5-HTTLPR) and major psychosesMolecular Psychiatry, 2002
- An International Study of the Relation between Somatic Symptoms and DepressionNew England Journal of Medicine, 1999
- Cloning and functional characterization of the human norepinephrine transporter gene promoterJournal of Neural Transmission, 1998
- The human serotonin transporter gene polymorphism-basic research and clinical implicationsJournal of Neural Transmission, 1997
- Life stressors, social resources, coping, and the 4-year course of unipolar depression.Journal of Abnormal Psychology, 1989
- Life stressors, social resources, coping, and the 4-year course of unipolar depression.Journal of Abnormal Psychology, 1989
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986